Interventional Pain Management Procedures: A Complete List & Guide

Interventional pain management is the medical subspecialty focused on diagnosing and treating pain through minimally invasive, image-guided procedures that target specific anatomical pain generators. Unlike pharmacological approaches, which rely on systemic medications, these procedures deliver treatment directly to...

Interventional Pain Management Procedures: A Complete List & Guide

What Is Interventional Pain Management?

Interventional pain management is the medical subspecialty focused on diagnosing and treating pain through minimally invasive, image-guided procedures that target specific anatomical pain generators. Unlike pharmacological approaches, which rely on systemic medications, these procedures deliver treatment directly to the source of pain, providing more precise relief with fewer systemic side effects.

The field of interventional pain management has grown rapidly over the past two decades, driven by advances in imaging technology, neuromodulation devices, and regenerative biologics. Today, interventional pain management encompasses a broad range of procedures from simple trigger point injections to complex spinal cord stimulator implantations. These procedures are performed by physicians, nurse practitioners, and physician assistants who have completed specialized training in pain medicine techniques.

According to the American Society of Interventional Pain Physicians (ASIPP), interventional pain management procedures reduce opioid consumption, improve functional outcomes, and lower overall healthcare costs compared to chronic opioid therapy alone. The growing evidence base supporting these procedures has positioned this discipline as a cornerstone of modern pain treatment, particularly as healthcare systems seek to reduce reliance on opioid medications.

This guide provides a comprehensive directory of interventional pain management procedures, covering indications, technique summaries, and the evidence supporting each approach. Whether you are a clinician seeking training or a patient exploring treatment options, this resource serves as a complete reference for understanding the interventional pain management landscape.

Epidural Steroid Injections

Epidural steroid injections (ESIs) are the most commonly performed interventional pain management procedure in the United States, with an estimated 9 million procedures performed annually. ESIs deliver a combination of corticosteroid and local anesthetic into the epidural space surrounding the spinal cord and nerve roots, reducing inflammation and pain signaling.

Indications

ESIs are indicated for lumbar and cervical radiculopathy caused by herniated discs, spinal stenosis, degenerative disc disease, and spondylolisthesis. They are also used for post-laminectomy syndrome and certain cases of axial neck or back pain with an inflammatory component. ESIs serve both diagnostic and therapeutic purposes, helping clinicians confirm the source of pain while providing meaningful relief.

Technique and Approaches

Three primary approaches are used for epidural access:

• Interlaminar: The needle is advanced between the laminae into the posterior epidural space. This approach provides broad coverage of multiple nerve root levels and is commonly used for spinal stenosis and multilevel pathology.
• Transforaminal: The needle is directed into the neural foramen, placing medication adjacent to a specific nerve root. This approach provides more targeted delivery and is preferred for single-level radiculopathy caused by a herniated disc.
• Caudal: The needle enters the epidural space through the sacral hiatus. This approach is technically straightforward and is often used for lower lumbar pathology, post-surgical adhesions, and patients with challenging spinal anatomy.

All three approaches are performed under fluoroscopic guidance with contrast confirmation to ensure accurate needle placement and medication delivery.

Evidence Level

The evidence supporting ESIs varies by indication and approach. A systematic review in Pain Physician found Level I evidence (strong) supporting transforaminal ESIs for lumbar radiculopathy, with 60 to 80 percent of patients reporting significant pain relief lasting three to six months (Manchikanti et al., Pain Physician, 2021). Evidence for cervical interlaminar ESIs is Level II (moderate), with consistent short-term benefits. Long-term outcomes beyond six months are less consistent, and current guidelines recommend a maximum of three to four ESIs per year per spinal region.

Facet Joint Injections and Medial Branch Blocks

Facet joints, also called zygapophyseal joints, are paired joints located at the posterior aspect of each spinal segment. They are a common source of axial back and neck pain, accounting for an estimated 15 to 45 percent of chronic low back pain cases and 36 to 67 percent of chronic neck pain. Procedures targeting the facet joints play a critical role in diagnosing and treating this prevalent pain generator.

Intra-Articular Facet Joint Injections

Intra-articular facet joint injections involve placing a needle directly into the facet joint capsule under fluoroscopic guidance and injecting a small volume of local anesthetic with or without a corticosteroid. These injections serve a primarily diagnostic role, confirming the facet joint as a pain source based on the patient's response to the local anesthetic. Therapeutic benefit from the corticosteroid component provides short-term relief, though evidence for sustained pain reduction from intra-articular injections alone is limited.

Medial Branch Blocks

Each facet joint is innervated by medial branches of the dorsal ramus at two spinal levels. Medial branch blocks involve injecting local anesthetic adjacent to these small nerves under fluoroscopic guidance. The International Spine Intervention Society (ISIS) recommends dual diagnostic medial branch blocks with at least 80 percent pain relief as the standard for confirming facet joint-mediated pain before proceeding to radiofrequency ablation.

Evidence Level

Diagnostic medial branch blocks have Level I evidence for identifying facet joint pain when performed using controlled, comparative blocks (Manchikanti et al., Pain Physician, 2020). Therapeutic medial branch blocks provide Level II evidence for short-term pain relief. The primary value of medial branch blocks in the diagnostic algorithm is prognostic, identifying patients who will benefit from radiofrequency ablation for longer-lasting relief.

Radiofrequency Ablation

Radiofrequency ablation (RFA), also known as radiofrequency neurotomy, is one of the most effective procedures in this specialty for achieving long-duration pain relief. RFA uses a specialized needle electrode to generate heat at the tip, creating a thermal lesion that disrupts the targeted nerve's ability to transmit pain signals. Relief typically lasts 6 to 18 months, and the procedure can be repeated when pain returns as the nerve regenerates.

Indications

RFA is indicated for facet joint pain in the cervical, thoracic, and lumbar spine following positive diagnostic medial branch blocks. It is also indicated for sacroiliac joint pain (lateral branch RFA), knee osteoarthritis (genicular nerve RFA), hip pain (articular branch RFA), and trigeminal neuralgia. Newer applications include RFA for shoulder pain and plantar fasciitis.

Technique Summary

Conventional RFA is performed under fluoroscopic guidance. After local anesthesia, a radiofrequency cannula is advanced to the target nerve under image guidance. Sensory and motor stimulation testing confirms proper needle placement before a thermal lesion is created at 80 degrees Celsius for 60 to 90 seconds. Multiple lesions are typically created at each level to ensure complete nerve coverage.

Variations

• Conventional thermal RFA: Creates a discrete lesion using continuous radiofrequency current at 80 degrees Celsius. The standard technique for medial branch neurotomy.
• Cooled RFA: Uses an internally water-cooled electrode that creates a larger, more spherical lesion. Particularly effective for sacroiliac joint and genicular nerve ablation where nerves have variable anatomical courses.
• Pulsed RFA: Delivers intermittent radiofrequency current without heating tissue to destructive temperatures. Used for dorsal root ganglion procedures and situations where motor nerve damage must be avoided. Mechanism is neuromodulatory rather than ablative.

Evidence Level

Lumbar medial branch RFA has Level I evidence for treating facet joint pain, with systematic reviews showing 50 percent or greater pain relief lasting 6 to 12 months in 60 to 80 percent of properly selected patients (Lee et al., Pain Medicine, 2021). Cervical medial branch RFA carries Level II evidence. Genicular nerve RFA for knee osteoarthritis has Level I evidence based on multiple randomized controlled trials demonstrating superior outcomes compared to sham procedures at six-month follow-up.

Spinal Cord Stimulation

Spinal cord stimulation (SCS) is an advanced neuromodulation procedure that uses implanted electrodes to deliver electrical impulses to the dorsal columns of the spinal cord. These impulses modulate pain signal transmission, replacing pain perception with paresthesia (tingling) or, in newer systems, providing pain relief without any perceptible sensation.

Indications

SCS is indicated for failed back surgery syndrome (the most common indication), complex regional pain syndrome (CRPS), refractory angina pectoris, peripheral neuropathy (particularly painful diabetic neuropathy), chronic radiculopathy unresponsive to conservative and interventional treatments, and arachnoiditis. Patient selection is critical to SCS outcomes, with psychological screening and a successful trial period being prerequisites for permanent implantation.

Technique Summary

SCS implantation occurs in two phases. The trial phase involves percutaneous placement of temporary lead(s) in the epidural space under fluoroscopic guidance. The patient wears an external generator for five to seven days to evaluate pain relief. If the trial achieves 50 percent or greater pain reduction and meaningful functional improvement, the patient proceeds to permanent implantation, where the leads are connected to a fully implantable pulse generator (IPG) placed in the subcutaneous tissue of the buttock or abdomen.

Current Technologies

• Traditional low-frequency SCS: Delivers tonic stimulation at 40 to 60 Hz, producing paresthesia in the area of pain. Effective but limited by positional variability and paresthesia-related discomfort.
• High-frequency SCS (HF10): Stimulates at 10,000 Hz without producing paresthesia. The SENZA-RCT demonstrated superiority over traditional SCS for back and leg pain (Kapural et al., Neurosurgery, 2022).
• Burst stimulation: Delivers closely spaced electrical impulses in bursts, mimicking natural neural firing patterns. Shown to be superior to tonic stimulation in several comparative trials.
• Dorsal root ganglion (DRG) stimulation: Targets the DRG specifically rather than the dorsal columns. Superior to traditional SCS for focal pain conditions such as CRPS and groin pain (Deer et al., Neuromodulation, 2019).
• Closed-loop SCS: Automatically adjusts stimulation parameters based on measured neural responses. The Evoke trial showed improved outcomes compared to open-loop systems.

Evidence Level

SCS has Level I evidence for failed back surgery syndrome and CRPS. Long-term data demonstrate sustained pain relief and opioid reduction over 5 to 10 years in properly selected patients. Cost-effectiveness analyses show that SCS becomes cost-neutral within two to three years compared to continued medical management and produces cost savings thereafter.

Trigger Point Injections

Trigger point injections (TPIs) are among the simplest yet most frequently performed procedures in pain medicine. They target myofascial trigger points, which are hyperirritable nodules within taut bands of skeletal muscle that produce local and referred pain patterns. Myofascial pain syndrome affects an estimated 85 percent of chronic pain patients at some point during their course of treatment.

Indications

TPIs are indicated for myofascial pain syndrome, tension-type headache, cervicogenic headache, temporomandibular disorder, fibromyalgia tender points, and chronic pelvic floor pain. They are particularly useful for patients whose pain has a significant muscular component contributing to functional limitation.

Technique Summary

The clinician identifies the trigger point through palpation, locating the taut band and reproducing the patient's referred pain pattern. A small-gauge needle is inserted directly into the trigger point, and a local anesthetic (lidocaine or bupivacaine) with or without a small volume of corticosteroid is injected. Some practitioners use dry needling (needle insertion without injection) to achieve a similar mechanical disruption of the trigger point. The local twitch response elicited during needle insertion confirms accurate placement.

Evidence Level

A systematic review in the Archives of Physical Medicine and Rehabilitation found Level II evidence supporting trigger point injections for myofascial pain syndrome, with most studies showing significant short-term pain relief (Cummings and White, Archives of Physical Medicine and Rehabilitation, 2001). The effectiveness of wet needling (injection) versus dry needling remains debated, with some evidence suggesting that the mechanical disruption of the trigger point is the primary therapeutic mechanism rather than the injected substance. TPIs are most effective when combined with stretching, physical therapy, and ergonomic modifications to prevent trigger point recurrence.

Trigger point injections represent an ideal entry-level procedure for clinicians building procedural skills. The AAOPM training catalog includes courses that teach TPI technique alongside other foundational injection skills.

Peripheral Joint Injections

Peripheral joint injections deliver medication directly into the joint capsule to reduce inflammation and pain. These procedures are performed across virtually every medical specialty that treats musculoskeletal conditions, from primary care to orthopedics to rheumatology.

Common Target Joints

• Knee: The most frequently injected large joint. Indications include osteoarthritis, rheumatoid arthritis, meniscal tears, and synovitis.
• Shoulder: Glenohumeral joint and subacromial bursa injections for adhesive capsulitis, rotator cuff tendinopathy, and bursitis.
• Hip: Fluoroscopic or ultrasound-guided injections for hip osteoarthritis, labral tears, and trochanteric bursitis.
• Sacroiliac joint: Fluoroscopic-guided injections for sacroiliac joint dysfunction and sacroiliitis.
• Small joints: Wrist, hand, ankle, and foot joints for arthritis, carpal tunnel syndrome (diagnostic), and synovitis.

Injectable Agents

• Corticosteroids: Triamcinolone, methylprednisolone, betamethasone, and dexamethasone provide anti-inflammatory and analgesic effects lasting two to six weeks. Current guidelines recommend limiting corticosteroid injections to three to four per joint per year.
• Hyaluronic acid (viscosupplementation): Restores joint lubrication and cushioning in osteoarthritic joints. Most commonly used in the knee, with three- to five-injection series providing relief lasting three to six months.
• Platelet-rich plasma: Biologic therapy that promotes tissue healing and modulates inflammation. Growing evidence supports PRP for knee osteoarthritis and tendinopathies.
• Local anesthetic: Used diagnostically to confirm the joint as a pain source and therapeutically for immediate pain relief during and after the procedure.

Evidence Level

Intra-articular corticosteroid injections have Level I evidence for short-term pain relief in knee osteoarthritis and rheumatoid arthritis (American College of Rheumatology, 2020). Hyaluronic acid injections have Level II evidence, with meta-analyses showing modest benefit over placebo that becomes more clinically relevant at 8 to 12 weeks post-injection. PRP injections have emerging Level I evidence for knee osteoarthritis, with recent meta-analyses demonstrating superiority over hyaluronic acid at 12-month follow-up.

Peripheral and Sympathetic Nerve Blocks

Nerve blocks are a fundamental category of pain procedures that involve injecting local anesthetic, with or without corticosteroid, adjacent to a specific nerve or nerve plexus. They serve both diagnostic and therapeutic purposes, providing targeted pain relief while simultaneously confirming the neural pathway responsible for the patient's symptoms.

Peripheral Nerve Blocks

• Greater occipital nerve block: Treats occipital neuralgia, cervicogenic headache, and migraine. Performed at the posterior base of the skull where the greater occipital nerve crosses the superior nuchal line.
• Suprascapular nerve block: Treats shoulder pain from adhesive capsulitis, rotator cuff disease, and post-surgical pain. Provides both diagnostic information and two to four weeks of therapeutic relief.
• Lateral femoral cutaneous nerve block: Treats meralgia paresthetica, a common entrapment neuropathy of the lateral thigh.
• Intercostal nerve block: Treats post-thoracotomy pain, rib fracture pain, and post-herpetic neuralgia of the thoracic dermatomes.
• Ilioinguinal and iliohypogastric nerve blocks: Treat chronic groin pain following hernia repair or lower abdominal surgery.

Sympathetic Nerve Blocks

• Stellate ganglion block: Targets the cervicothoracic sympathetic chain. Indicated for CRPS of the upper extremity, phantom limb pain, and vascular insufficiency of the arm.
• Lumbar sympathetic block: Targets the lumbar sympathetic chain at L2-L4. Indicated for CRPS of the lower extremity, phantom limb pain, peripheral vascular disease, and hyperhidrosis.
• Celiac plexus block: Targets the celiac plexus anterior to the aorta at the L1 level. Indicated for intractable abdominal pain from pancreatic cancer and chronic pancreatitis.
• Superior hypogastric plexus block: Treats chronic pelvic pain, including pain from endometriosis, interstitial cystitis, and pelvic malignancies.

Evidence Level

Greater occipital nerve blocks have Level II evidence for cervicogenic headache and migraine prophylaxis. Stellate ganglion blocks have Level II evidence for CRPS of the upper extremity. Celiac plexus neurolysis has Level I evidence for pain from pancreatic cancer, with systematic reviews demonstrating superior pain relief compared to opioid therapy alone (Zhong et al., Pain Practice, 2022). Peripheral nerve blocks in the perioperative setting have Level I evidence for reducing opioid requirements and improving recovery.

Vertebroplasty and Kyphoplasty

Vertebroplasty and kyphoplasty are minimally invasive procedures designed to treat painful vertebral compression fractures (VCFs), which affect approximately 750,000 Americans annually. These fractures are most common in patients with osteoporosis and can cause severe, debilitating pain that limits mobility and independence.

Vertebroplasty

Vertebroplasty involves the percutaneous injection of polymethylmethacrylate (PMMA) bone cement into the collapsed vertebral body under fluoroscopic guidance. The cement stabilizes the fracture, reduces micromotion-induced pain, and may also exert an analgesic effect through thermal destruction of pain-sensing nerve endings within the vertebra. The procedure is performed through a transpedicular or parapedicular approach using an 11- to 13-gauge bone biopsy needle.

Kyphoplasty

Kyphoplasty adds a preliminary step to vertebroplasty: insertion of an inflatable bone tamp (balloon) into the fractured vertebral body before cement injection. The balloon creates a cavity within the compressed bone and partially restores vertebral body height. After the balloon is deflated and removed, PMMA cement is injected into the cavity at lower pressure than traditional vertebroplasty, theoretically reducing the risk of cement extravasation.

Evidence Level

The evidence for vertebral augmentation procedures has been debated. Two high-profile randomized controlled trials (Buchbinder et al., NEJM, 2009; Kallmes et al., NEJM, 2009) found no significant difference between vertebroplasty and sham procedures. However, subsequent trials with improved patient selection criteria, particularly the VAPOUR trial (Clark et al., Lancet, 2016), demonstrated significant benefit for vertebroplasty in patients with acute fractures (less than six weeks) and bone marrow edema on MRI. Current evidence supports vertebral augmentation as an interventional pain management option for acute, symptomatic compression fractures with MRI-confirmed edema that fail conservative management after two to three weeks.

Intrathecal Drug Delivery Systems

Intrathecal drug delivery systems (IDDS), commonly known as pain pumps, deliver medication directly into the cerebrospinal fluid surrounding the spinal cord. This approach bypasses the blood-brain barrier, allowing dramatically lower doses of medication to achieve effective pain relief compared to oral administration. Typical intrathecal doses are 1/300th of the equivalent oral dose, significantly reducing systemic side effects.

Indications

IDDS are indicated for patients with chronic, intractable pain who have failed conservative therapies and less invasive interventional procedures. Common indications include cancer-related pain (the original indication for intrathecal pumps), failed back surgery syndrome, CRPS, and neuropathic pain unresponsive to other treatments. Patient selection requires psychological screening and a successful intrathecal trial demonstrating at least 50 percent pain relief.

Technique Summary

Implantation involves placing a catheter into the intrathecal space, typically at the thoracic or upper lumbar level, and tunneling it subcutaneously to a programmable pump placed in the abdomen. The pump reservoir holds medication and delivers it at a programmed rate that can be adjusted externally using a wireless programmer. Pump refills are performed every one to three months via percutaneous injection into the pump's access port.

Evidence Level

Intrathecal drug delivery has Level I evidence for cancer-related pain, with multiple randomized controlled trials demonstrating superior pain relief and lower side effect burden compared to comprehensive medical management (Smith et al., Journal of Clinical Oncology, 2002). For chronic non-cancer pain, evidence is Level II, with long-term observational studies showing sustained pain relief and improved function in carefully selected patients. The Polyanalgesic Consensus Conference (PACC) provides evidence-based guidelines for intrathecal medication selection and dosing in interventional pain management.

Regenerative Pain Procedures

Regenerative pain procedures aim to repair damaged tissues rather than simply reducing pain signals. These biological therapies represent a growing frontier in the field, offering the potential for disease modification rather than symptom management alone.

Platelet-Rich Plasma (PRP) Injections

PRP involves concentrating platelets from the patient's blood and injecting the preparation into damaged joints, tendons, or ligaments. The concentrated growth factors promote tissue healing, reduce inflammation, and modulate pain signaling. PRP has Level I evidence for lateral epicondylitis and knee osteoarthritis, with meta-analyses showing superior outcomes compared to corticosteroid injections at 12-month follow-up. The AAOPM PRP training program prepares providers for clinical implementation of this increasingly popular interventional approach.

Prolotherapy

Prolotherapy involves injecting a hypertonic dextrose solution (typically 12.5 to 25 percent) into damaged ligaments, tendons, and joints to stimulate a controlled inflammatory response and promote tissue repair. Level II evidence supports prolotherapy for chronic low back pain, knee osteoarthritis, and lateral epicondylitis. The treatment is particularly useful for hypermobility-related pain conditions and ligamentous laxity.

Bone Marrow Aspirate Concentrate (BMAC)

BMAC involves harvesting bone marrow from the iliac crest, concentrating the mesenchymal stem cells and growth factors, and injecting the concentrate into damaged joints or tissues. While clinical trials are ongoing, early results show promise for knee osteoarthritis, avascular necrosis, and non-union fractures. BMAC requires more specialized equipment and training than PRP but shares the advantage of using the patient's own biological material.

Evidence Level

Regenerative procedures vary in their evidence base. PRP has Level I evidence for specific indications. Prolotherapy has Level II evidence. BMAC has Level III to IV evidence (case series and pilot studies), with multiple large randomized controlled trials currently in progress. The field is evolving rapidly, and providers should stay current with emerging data through continuing medical education.

Emerging Interventional Techniques

The field of interventional pain management continues to advance with new technologies and techniques that expand treatment options for patients with complex pain conditions.

Peripheral Nerve Stimulation

Peripheral nerve stimulation (PNS) involves placing electrodes adjacent to peripheral nerves to modulate pain signaling. Recent FDA approvals for temporary and permanent PNS systems have expanded indications to include post-surgical pain, post-amputation pain, chronic shoulder pain, and peripheral neuropathy. The advantage of PNS over spinal cord stimulation is its ability to target focal pain with a less invasive procedure.

Intradiscal Procedures

Several newer procedures target the intervertebral disc directly. Intradiscal biacuplasty uses bipolar radiofrequency probes to heat the posterior annulus fibrosus, destroying nociceptive fibers within the disc. Intradiscal PRP injections aim to promote healing of degenerative disc tissue. Both approaches target discogenic pain, a common diagnosis that has historically been difficult to treat with traditional injections.

Cryoneurolysis

Cryoneurolysis (cryotherapy nerve ablation) uses extreme cold to create a nerve lesion without destroying the nerve sheath, allowing complete nerve regeneration. This technique is being studied for genicular nerve treatment in knee osteoarthritis, intercostal neuralgia, and perioperative pain management. The potential advantage over thermal RFA is more predictable nerve recovery and reduced risk of neuroma formation.

Image-Guided Ultrasound Procedures

Ultrasound guidance is increasingly replacing fluoroscopy for certain pain procedures. Advantages include real-time visualization of soft tissues, absence of radiation exposure, portability, and lower cost. Ultrasound-guided procedures now include peripheral nerve blocks, trigger point injections, joint injections, tendon fenestration, and PRP delivery. The expansion of ultrasound-guided techniques has made these procedures more accessible in outpatient and primary care settings.

How Providers Choose the Right Procedure

Selecting the appropriate interventional pain management procedure requires systematic clinical decision-making that integrates patient history, physical examination, imaging findings, and response to prior treatments. The goal is to identify the anatomical pain generator and match it with the intervention most likely to provide meaningful, lasting relief.

Diagnostic Algorithm

The standard diagnostic approach begins with a thorough history and physical examination to develop a differential diagnosis. Imaging studies including MRI, CT, and X-rays help identify structural pathology. Diagnostic injections such as medial branch blocks, selective nerve root blocks, and intra-articular joint injections confirm the pain source before proceeding to longer-lasting therapeutic interventions.

Treatment Ladder

Most clinical guidelines recommend a stepwise approach:

1. Conservative measures: Physical therapy, non-opioid medications, and lifestyle modifications.
2. Basic interventional procedures: Trigger point injections, joint injections, epidural steroid injections.
3. Intermediate procedures: Nerve blocks, radiofrequency ablation, regenerative injections.
4. Advanced interventions: Spinal cord stimulation, intrathecal drug delivery, vertebral augmentation.

This ladder approach ensures that patients receive the least invasive effective treatment first, progressing to more complex procedures only when simpler approaches fail to provide adequate relief.

Evidence-Based Patient Selection

Successful outcomes depend heavily on patient selection. Key factors include confirmation of the anatomical pain generator through diagnostic procedures, realistic patient expectations about outcomes, absence of untreated psychological comorbidities that may impair treatment response, and willingness to participate in multimodal care including physical therapy and behavioral health interventions when indicated.

Training and Certification in Interventional Pain Management

Performing these procedures requires specialized training beyond standard medical or nursing education. The procedural skills, image guidance techniques, and clinical decision-making involved demand structured hands-on education under expert supervision.

Traditional Fellowship Pathway

For physicians, the traditional pathway is completion of an ACGME-accredited pain medicine fellowship following residency in anesthesiology, physical medicine and rehabilitation, neurology, or psychiatry. These one-year fellowships provide comprehensive training in the full spectrum of interventional procedures.

AAOPM Training Programs

The American Academy of Procedural Medicine (AAOPM) offers an alternative pathway for physicians, nurse practitioners, and physician assistants who want to build interventional pain management skills through targeted, hands-on training courses. AAOPM programs focus on the practical procedural competencies needed to perform specific interventions, with CME-approved courses covering injection techniques, ultrasound guidance, PRP preparation, and other core interventional skills.

AAOPM's model is particularly valuable for clinicians who are already in practice and want to add procedural pain services without completing a full fellowship. Weekend-based courses minimize time away from practice, and the modular structure allows providers to build skills incrementally based on their clinical interests and patient population needs.

Continuing Education Requirements

Maintaining competency requires ongoing education as techniques evolve, new devices enter the market, and evidence updates change clinical practice. Professional organizations including ASIPP, the American Academy of Pain Medicine (AAPM), and AAOPM offer continuing medical education programs that keep practitioners current with advances in the field. Many state medical boards require specific pain management CME hours for license renewal, reflecting the growing regulatory focus on pain care quality.

Frequently Asked Questions

What is the most common interventional pain management procedure?

Epidural steroid injections are the most commonly performed procedure in the field, with approximately 9 million procedures performed annually. Trigger point injections and joint injections are also performed at very high volumes across multiple specialties. The choice of procedure depends on the specific pain diagnosis, with each intervention targeting a different anatomical pain generator.

How long does pain relief last from interventional procedures?

Duration of relief varies significantly by procedure. Trigger point injections provide days to weeks of relief. Epidural steroid injections typically last three to six months. Radiofrequency ablation provides 6 to 18 months of relief. Spinal cord stimulation offers continuous relief for the life of the device. Regenerative procedures like PRP may produce progressive improvement over three to six months with effects lasting a year or more. Relief duration also depends on the underlying condition, patient factors, and whether the procedure is combined with physical therapy and other treatments.

Are interventional pain management procedures covered by insurance?

Most established interventional pain management procedures are covered by Medicare and major commercial insurance plans when performed for approved indications with appropriate documentation. Epidural steroid injections, nerve blocks, radiofrequency ablation, spinal cord stimulation, and intrathecal pumps all have established insurance coverage pathways. Newer and regenerative procedures such as PRP and BMAC injections may not be covered by all payers. Prior authorization is often required for advanced procedures like SCS and IDDS implantation.

Who can perform interventional pain management procedures?

Interventional pain management procedures are performed by physicians (MD/DO) with training in pain medicine, anesthesiology, physical medicine and rehabilitation, or related specialties. In many states, nurse practitioners and physician assistants with appropriate training and supervision can also perform certain interventional procedures. Credentialing requirements vary by institution and state. Organizations like AAOPM provide the structured training that institutions look for when credentialing providers for interventional procedures.

What are the risks of interventional pain management procedures?

All interventional procedures carry risks, though serious complications are uncommon when procedures are performed by trained providers using proper image guidance. General risks include bleeding, infection, nerve injury, and allergic reaction to injected medications. Procedure-specific risks include headache from dural puncture during epidural injections, pneumothorax from cervical procedures, and lead migration from spinal cord stimulator implantation. Providers minimize these risks through proper training, image guidance, sterile technique, and careful patient selection.

How do I know which interventional pain management procedure is right for me?

The appropriate procedure depends on your specific pain diagnosis, which is determined through clinical evaluation including history, physical examination, imaging, and diagnostic injections. A pain management specialist will identify the anatomical source of your pain and recommend the intervention most likely to provide relief. For example, facet joint pain is best treated with medial branch blocks followed by radiofrequency ablation, while radicular pain from a herniated disc responds best to transforaminal epidural steroid injections. A comprehensive evaluation is always the first step.

Can interventional pain management replace opioid medications?

For many patients, these procedures significantly reduce or eliminate the need for opioid medications. Studies consistently show that procedures like spinal cord stimulation reduce opioid consumption by 50 to 80 percent, and nerve blocks reduce postoperative opioid needs by 50 to 70 percent. Multimodal interventional approaches that combine procedures with physical therapy and non-opioid medications provide the best opportunity for achieving meaningful pain relief without opioid dependence.

Get Trained in Interventional Pain Management

The field represents the future of pain treatment. As healthcare systems prioritize opioid reduction, functional restoration, and targeted therapies, clinicians with interventional skills are positioned to lead the evolution of pain care.

The American Academy of Procedural Medicine (AAOPM) offers hands-on, CME-approved training programs that prepare physicians, nurse practitioners, and physician assistants to perform the interventional pain management procedures outlined in this guide. From foundational injection techniques to advanced regenerative approaches, AAOPM courses provide the practical skill development that translates directly into clinical practice.

Explore AAOPM's Interventional Pain Management Certification or browse the full course catalog to find training sessions in your area. Build the procedural skills your patients need and your practice deserves.